These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10365122

  • 1. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children.
    Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M.
    Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122
    [Abstract] [Full Text] [Related]

  • 2. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M.
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [Abstract] [Full Text] [Related]

  • 3. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM, Kenney MT, Simms LA, Smith SI, Kida Y, Smith PJ.
    Hum Mutat; 1995 Feb; 5(3):221-7. PubMed ID: 7599632
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G, Kobos J, Łoś E, Trejster E, Szymik-Kontorowicz S, Daszkiewicz P.
    Med Sci Monit; 2001 Feb; 7(6):1224-9. PubMed ID: 11687734
    [Abstract] [Full Text] [Related]

  • 5. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ, Wang ZY, Deuel TF, Xu YH.
    Biochem Biophys Res Commun; 1999 Jan 08; 254(1):197-9. PubMed ID: 9920757
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G, Kobos J, Łoś E, Trejster E, Szymik-Kantorowicz S, Daszkiewicz P.
    Eur J Surg Oncol; 2002 Feb 08; 28(1):67-71. PubMed ID: 11869017
    [Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity at 7p in Wilms' tumour development.
    Powlesland RM, Charles AK, Malik KT, Reynolds PA, Pires S, Boavida M, Brown KW.
    Br J Cancer; 2000 Jan 08; 82(2):323-9. PubMed ID: 10646884
    [Abstract] [Full Text] [Related]

  • 8. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S, Royer-Pokora B.
    Oncogene; 1999 Apr 15; 18(15):2533-6. PubMed ID: 10229205
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S, Becker KF, Braungart E, Reichmuth C, Klamt B, Becker I, Atkinson M, Gessler M, Höfler H.
    J Pathol; 2000 Jun 15; 191(2):162-9. PubMed ID: 10861576
    [Abstract] [Full Text] [Related]

  • 10. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK, Brown KW, Berry PJ.
    Am J Pathol; 1998 Sep 15; 153(3):991-1000. PubMed ID: 9736048
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P, Telzerow P, Moksness J, Breslow NE.
    Med Pediatr Oncol; 1996 Nov 15; 27(5):429-33. PubMed ID: 8926924
    [Abstract] [Full Text] [Related]

  • 12. The role of Wilms' tumor genes.
    Hirose M.
    J Med Invest; 1999 Aug 15; 46(3-4):130-40. PubMed ID: 10687307
    [Abstract] [Full Text] [Related]

  • 13. WT1 splicing alterations in Wilms' tumors.
    Baudry D, Hamelin M, Cabanis MO, Fournet JC, Tournade MF, Sarnacki S, Junien C, Jeanpierre C.
    Clin Cancer Res; 2000 Oct 15; 6(10):3957-65. PubMed ID: 11051244
    [Abstract] [Full Text] [Related]

  • 14. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
    Wagner KJ, Roberts SG.
    Biochem Soc Trans; 2004 Dec 10; 32(Pt 6):932-5. PubMed ID: 15506928
    [Abstract] [Full Text] [Related]

  • 16. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
    Ramani P, Cowell JK.
    J Pathol; 1996 Jun 10; 179(2):162-8. PubMed ID: 8758208
    [Abstract] [Full Text] [Related]

  • 17. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS.
    J Natl Cancer Inst; 1997 Aug 06; 89(15):1148-52. PubMed ID: 9262253
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V.
    Genes Chromosomes Cancer; 2005 Jun 06; 43(2):172-80. PubMed ID: 15761866
    [Abstract] [Full Text] [Related]

  • 19. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ.
    Clin Cancer Res; 2000 Nov 06; 6(11):4265-71. PubMed ID: 11106242
    [Abstract] [Full Text] [Related]

  • 20. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
    Gupta S, Joshi K, Wig JD, Arora SK.
    Indian J Cancer; 2009 Nov 06; 46(4):303-10. PubMed ID: 19749460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.